stenting with the Coroflex ISAR sirolimus-eluting stent

DEVICE2 trials

Sponsors

B. Braun Melsungen AG

Conditions

Coronary Artery Disease (CAD)

Unknown Phase

Coroflex ISAR 2000 Registry

CompletedNCT02629575

B. Braun Melsungen AGCoronary Artery Disease (CAD)

Start: 2014-01-31End: 2017-12-31Updated: 2018-03-13

Coroflex ISAR 2000 Extended Registry (ISAR2000 Extended)

CompletedNCT02905214

B. Braun Melsungen AGCoronary Artery Disease (CAD)

Start: 2016-01-31End: 2021-12-31Updated: 2022-02-08

Related Papers

Impact of Coronary Stent Architecture on Clinical Outcomes: Do Minor Changes in Stent Architecture Really Matter?

Cardiology and Therapy2020-12-041 citations

Clinical outcomes following polymer-free sirolimus-eluting stent implantations in unselected patients

Medicine2020-07-171 citations

Real-World Dual Antiplatelet Therapy Following Polymer-Free Sirolimus-Eluting Stent Implantations to Treat Coronary Artery Disease.

2020-06-017 citations

Unrestricted use of polymer-free sirolimus eluting stents in routine clinical practice

Medicine2020-02-018 citations

Polymer-free sirolimus-eluting stent use in Europe and Asia: Ethnic differences in demographics and clinical outcomes.

2020-01-135 citations

Nine-month clinical outcomes in patients with diabetes treated with polymer-free sirolimus-eluting stents and 6‑month vs. 12‑month dual-antiplatelet therapy (DAPT).

2018-01-224 citations

9-month results of polymer-free sirolimus eluting stents in young patients compared to a septuagenarian and octogenarian all-comer population.

2017-12-042 citations

Propensity score matched all comers population treated with ultra‐thin strut bare metal and sirolimus‐probucol coated drug‐eluting stents of identical stent architecture

Catheterization and Cardiovascular Interventions2017-09-256 citations

Polymer-free sirolimus-eluting stents in a large-scale all-comers population

Open Heart2017-06-0621 citations